Mild to Moderate Depression.

2

Review clinical trials related to Mild to Moderate Depression.. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Probiotics for Depressive Symptomatology and Neural Activity.

This study aims to investigate the acute and chronic effects of 16-week probiotic supplementation (Ecologic® Barrier) on depressive symptoms and neural activity in those with mild-to-moderate depression.

Participants needed: 76
Trial details
Age: 25-40Biological sex: AllType: InterventionalSponsor: University of ReadingUpdated: Jun 25, 2026Locations: 1
Eligibility criteria

Mild to moderate depression symptoms (BDI-II 12-28) [+3]

Taking antidepressants (up to 2 months prior to inclusion) [+9]

Status: Recruiting

Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression

Cognitive deficits, including working memory deficits, are often present in depression and there are currently no effective pharmacological treatments targeting working memory deficits. Papassotiropoulos et al. (2024) has recently demonstrated that fampridine, a potassium channel blocker, can enhance working memory in healthy individuals with lower baseline performance, suggesting it may hold potential for addressing cognitive deficits in clinical populations. The primary aim of this study is to evaluate whether fampridine improves working memory performance in mild to moderate depression

Participants needed: 38
Trial details
Phase: Phase 2Age: 18-55Biological sex: AllType: InterventionalSponsor: University of BaselUpdated: Dec 12, 2025Locations: 1
Eligibility criteria

Male or female [+6]

Contraindications to the class of drugs under study, e.g. known hypersensitivity... [+23]